[Form 3] MiniMed Group, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

MiniMed Group, Inc. director Endicott David J. filed an initial Form 3, which is a statement of beneficial ownership for company insiders. The filing shows no reported transactions and no listed holdings of MiniMed Group securities in the provided data.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3, which is a statement of beneficial ownership for company insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"The reporting person is Endicott David J., identified as a director"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/06/2026 - 05:55 PM Accepted by SEC EDGAR 07/06/2026 - 05:54 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Endicott David J.

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/29/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does MiniMed Group (MMED) disclose in this Form 3?

MiniMed Group reports that director Endicott David J. filed an initial Form 3. The data provided shows no transactions and no listed holdings of MMED securities at the time of this filing.

Who is the reporting person in MiniMed Group (MMED)’s Form 3?

The reporting person is Endicott David J., identified as a director of MiniMed Group, Inc. Form 3 establishes his status as an insider subject to SEC reporting rules for future ownership changes.

Are there any buy or sell transactions reported for MMED in this Form 3?

No transactions are reported. The transaction summary shows zero buys, zero sells and no derivative exercises or other dispositions, indicating this is purely an initial ownership statement without trading activity.

Does Endicott David J. report any MiniMed Group (MMED) holdings on this Form 3?

The summarized data shows no listed holdings, with holding entries equal to zero. This means no specific MMED share or derivative positions are disclosed in the excerpted Form 3 information.

Why is a Form 3 important for MiniMed Group (MMED) investors?

Form 3 formally identifies new insiders like directors or large shareholders. It establishes a baseline for future Form 4 and Form 5 filings, which will disclose any subsequent changes in their MMED ownership positions.